Identification of a Biomarker Signature to Predict the Need for Chemotherapy in Patients With Hormone Receptor Positive Breast Cancer

被引：0
|
作者：
Korf, U. [1 ]
Sonntag, J. [1 ]
Bender, C. [1 ]
Wiemann, S. [1 ]
Aulmann, S. [2 ]
Sinn, P. [2 ]
Burwinkel, B. [2 ]
Schneeweiss, A. [3 ]
Beissbarth, T. [4 ]
机构：
[1] German Canc Res Ctr, Heidelberg, Germany
[2] Univ Clin Heidelberg, Heidelberg, Germany
[3] Natl Ctr Tumor Dis Heidelberg, Gynecol Oncol Sect, Heidelberg, Germany
[4] Univ Med Ctr Gottingen, Gottingen, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71480-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
847
引用
收藏
页码：S203 / S204
页数：2
相关论文
共 50 条
  • [31] The Immunology of Hormone Receptor Positive Breast Cancer
    Goldberg, Jonathan
    Pastorello, Ricardo G.
    Vallius, Tuulia
    Davis, Janae
    Cui, Yvonne Xiaoyong
    Agudo, Judith
    Waks, Adrienne G.
    Keenan, Tanya
    McAllister, Sandra S.
    Tolaney, Sara M.
    Mittendorf, Elizabeth A.
    Guerriero, Jennifer L.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [32] Deep learning-based predictive biomarker for adjuvant chemotherapy in early-stage hormone receptor-positive breast cancer
    Cho, Soo Youn
    Cho, Eun Yoon
    Paeng, Kyunghyun
    Jung, Geunyoung
    Lee, Sarah
    Song, Sang Yong
    CANCER RESEARCH, 2019, 79 (13)
  • [33] Protein biomarker signature for risk classification of hormone receptor positive breast cancer identified by reverse phase protein array based tumor profiling
    Sonntag, J.
    Bender, C.
    Aulmann, S.
    Von der Heyde, S.
    Burwinkel, B.
    Wiemann, S.
    Beissbarth, T.
    Sinn, H. P.
    Schneeweiss, A.
    Korf, U.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S212 - S212
  • [34] Metabolic biomarker signature for predicting the effect of neoadjuvant chemotherapy of breast cancer
    Lin, Xiaojie
    Xu, Rui
    Mao, Siying
    Zhang, Yuzhu
    Dai, Yan
    Guo, Qianqian
    Song, Xue
    Zhang, Qingling
    Li, Li
    Chen, Qianjun
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (22)
  • [35] Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer
    He, Menglin
    Hu, Cheng
    Deng, Jian
    Ji, Hui
    Tian, Weiqian
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [36] Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer
    Menglin He
    Cheng Hu
    Jian Deng
    Hui Ji
    Weiqian Tian
    World Journal of Surgical Oncology, 19
  • [37] The role of chemotherapy in hormone receptor-positive and HER2-positive breast cancer patients over age 70.
    Caggiano, Vincent
    Parise, Carol
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients
    Chenpu Xu
    Qun Wei
    Jufeng Guo
    Ji Chun Zhou
    Jin Mei
    Zhi Nong Jiang
    Jian Guo Shen
    Lin Bo Wang
    Annals of Surgical Oncology, 2015, 22 : 2034 - 2039
  • [39] FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients
    Xu, Chenpu
    Wei, Qun
    Guo, Jufeng
    Zhou, Ji Chun
    Mei, Jin
    Jiang, Zhi Nong
    Shen, Jian Guo
    Wang, Lin Bo
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (06) : 2034 - 2039
  • [40] Phagocytosis-Regulators-Based Signature to Predict the Prognosis and Chemotherapy Resistance for Breast Cancer Patients
    Feng, Juan
    Ren, Jun
    Li, Xiuqi
    Zhang, Xue
    Yang, Qingfeng
    Wu, Zankai
    Cui, Le
    Liao, Lingxia
    Gong, Yiping
    Cao, Dedong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
12345